相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Risk-of-bias VISualization (robvis): An R package and Shiny web app for visualizing risk-of-bias assessments
Luke A. McGuinness et al.
RESEARCH SYNTHESIS METHODS (2021)
Estimating the potential impact of implementing pre-emptive pharmacogenetic testing in primary care across the UK
Essra Youssef et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2021)
PRISMA 2020 explanation and elaboration: updated guidance and exemplars for reporting systematic reviews
Matthew J. Page et al.
BMJ-BRITISH MEDICAL JOURNAL (2021)
The PRISMA 2020 statement: an updated guideline for reporting systematic reviews
Matthew J. Page et al.
BMJ-BRITISH MEDICAL JOURNAL (2021)
Results of the CYP-GUIDES randomized controlled trial: Total cohort and primary endpoints
Gualberto Ruano et al.
CONTEMPORARY CLINICAL TRIALS (2020)
Drug-drug-gene interactions and adverse drug reactions
Mustafa Adnan Malki et al.
PHARMACOGENOMICS JOURNAL (2020)
Implementation of Pharmacogenetics in Primary Care: A Multi-Stakeholder Perspective
Tessel Rigter et al.
FRONTIERS IN GENETICS (2020)
Pharmacogenomics for Primary Care: An Overview
Victoria Rollinson et al.
GENES (2020)
A Continuing Professional Development Program for Pharmacists Implementing Pharmacogenomics into Practice
Natalie Crown et al.
PHARMACY (2020)
Analysis of comprehensive pharmacogenomic profiling to impact in-hospital prescribing
Yee Ming Lee et al.
PHARMACOGENETICS AND GENOMICS (2019)
Are Randomized Controlled Trials Necessary to Establish the Value of Implementing Pharmacogenomics in the Clinic?
Rachel Huddart et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2019)
Impact of pharmacogenomics on clinical outcomes in major depressive disorder in the GUIDED trial: A large, patient- and rater-blinded, randomized, controlled study
John F. Greden et al.
JOURNAL OF PSYCHIATRIC RESEARCH (2019)
Pharmacist-Initiated Pre-Emptive Pharmacogenetic Panel Testing with Clinical Decision Support in Primary Care: Record of PGx Results and Real-World Impact
Cathelijne H. van der Wouden et al.
GENES (2019)
A pilot study of the implementation of pharmacogenomic pharmacist initiated pre-emptive testing in primary care
Paul C. D. Bank et al.
EUROPEAN JOURNAL OF HUMAN GENETICS (2019)
RoB 2: a revised tool for assessing risk of bias in randomised trials
Jonathan A. C. Sterne et al.
BMJ-BRITISH MEDICAL JOURNAL (2019)
Polypharmacy in an Elderly Population: Enhancing Medication Management Through the Use of Clinical Decision Support Software Platforms
Dorothy Keine et al.
NEUROLOGY AND THERAPY (2019)
Translating pharmacogenomics into clinical decisions: do not let the perfect be the enemy of the good
Kristi Krebs et al.
HUMAN GENOMICS (2019)
A Core Outcome Set for Multimorbidity Research (COSmm)
Susan M. Smith et al.
ANNALS OF FAMILY MEDICINE (2018)
Polypharmacy prevalence among older adults based on the survey of health, ageing and retirement in Europe
Luis Midao et al.
ARCHIVES OF GERONTOLOGY AND GERIATRICS (2018)
Improved efficacy with targeted pharmacogenetic-guided treatment of patients with depression and anxiety: A randomized clinical trial demonstrating clinical utility
Paul Bradley et al.
JOURNAL OF PSYCHIATRIC RESEARCH (2018)
Genetic testing as a supporting tool in prescribing psychiatric medication: Design and protocol of the IMPACT study
Deanna Herbert et al.
JOURNAL OF PSYCHIATRIC RESEARCH (2018)
Pharmacogenomic Approach to Selecting Antiplatelet Therapy in Patients With Acute Coronary Syndromes The PHARMCLO Trial
Francesca Maria Notarangelo et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2018)
Prevalence and Preventability of Drug-Related Hospital Readmissions: A Systematic Review
Najla El Morabet et al.
JOURNAL OF THE AMERICAN GERIATRICS SOCIETY (2018)
Core Outcome Set for Trials Aimed at Improving the Appropriateness of Polypharmacy in Older People in Primary Care
Audrey Rankin et al.
JOURNAL OF THE AMERICAN GERIATRICS SOCIETY (2018)
What do we need to transfer pharmacogenetics findings into the clinic?
Elise M. A. Slob et al.
PHARMACOGENOMICS (2018)
Comparison of the Guidelines of the Clinical Pharmacogenetics Implementation Consortium and the Dutch Pharmacogenetics Working Group
P. C. D. Bank et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2018)
Effects of Delivering SLCO1B1 Pharmacogenetic Information in Randomized Trial and Observational Settings
Bruce Peyser et al.
CIRCULATION-GENOMIC AND PRECISION MEDICINE (2018)
Clinical Implementation of Pharmacogenomics for Personalized Precision Medicine: Barriers and Solutions
Michelle E. Klein et al.
JOURNAL OF PHARMACEUTICAL SCIENCES (2017)
Avoidable drug-gene conflicts and polypharmacy interactions in patients participating in a personalized medicine program
Kristen K. Reynolds et al.
PERSONALIZED MEDICINE (2017)
Preemptive Panel-Based Pharmacogenetic Testing: The Time is Now
Kristin W. Weitzel et al.
PHARMACEUTICAL RESEARCH (2017)
Multimorbidity, polypharmacy and pharmacogenomics in old age
Juergen Brockmoeller et al.
PHARMACOGENOMICS (2017)
Pharmacists' confidence when providing pharmaceutical care on anticoagulants, a multinational survey
John Papastergiou et al.
INTERNATIONAL JOURNAL OF CLINICAL PHARMACY (2017)
Clinical impact of pharmacogenetic profiling with a clinical decision support tool in polypharmacy home health patients: A prospective pilot randomized controlled trial
Lindsay S. Elliott et al.
PLOS ONE (2017)
Implementing Pharmacogenomics in Europe: Design and Implementation Strategy of the Ubiquitous Pharmacogenomics Consortium
C. H. van der Wouden et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2017)
The effect of pharmacogenetic profiling with a clinical decision support tool on healthcare resource utilization and estimated costs in the elderly exposed to polypharmacy
D. Brixner et al.
JOURNAL OF MEDICAL ECONOMICS (2016)
It could be a 'Golden Goose': a qualitative study of views in primary care on an emergency admission risk prediction tool prior to implementation
Alison Porter et al.
BMC FAMILY PRACTICE (2016)
Genetic Variation Among 82 Pharmacogenes: The PGRNseq Data From the eMERGE Network
W. S. Bush et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2016)
Contribution of Pharmacogenetic Testing to Modeled Medication Change Recommendations in a Long-Term Care Population with Polypharmacy
Elaine A. Sugarman et al.
DRUGS & AGING (2016)
A brighter future for the implementation of pharmacogenomic testing
Cathelijne H. van der Wouden et al.
EUROPEAN JOURNAL OF HUMAN GENETICS (2016)
Preemptive Pharmacogenomic Testing for Precision Medicine A Comprehensive Analysis of Five Actionable Pharmacogenomic Genes Using Next-Generation DNA Sequencing and a Customized CYP2D6 Genotyping Cascade
Yuan Ji et al.
JOURNAL OF MOLECULAR DIAGNOSTICS (2016)
Implementation of Clinical Pharmacogenomics within a Large Health System: From Electronic Health Record Decision Support to Consultation Services
J. Kevin Hicks et al.
PHARMACOTHERAPY (2016)
ROBINS-I: a tool for assessing risk of bias in non-randomised studies of interventions
Jonathan A. C. Sterne et al.
BMJ-BRITISH MEDICAL JOURNAL (2016)
ROBINS-I: a tool for assessing risk of bias in non-randomised studies of interventions
Jonathan A. C. Sterne et al.
BMJ-BRITISH MEDICAL JOURNAL (2016)
Examining perceptions of the usefulness and usability of a mobile-based system for pharmacogenomics clinical decision support: a mixed methods study
Kathrin Blagec et al.
PEERJ (2016)
ASHP Statement on the Pharmacist's Role in Clinical Pharmacogenomics
AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY (2015)
Preemptive Clinical Pharmacogenetics Implementation: Current Programs in Five US Medical Centers
Henry M. Dunnenberger et al.
ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY, VOL 55 (2015)
The rising tide of polypharmacy and drug-drug interactions: population database analysis 1995-2010
Bruce Guthrie et al.
BMC MEDICINE (2015)
Identification of Patients With Variants in TPMT and Dose Reduction Reduces Hematologic Events During Thiopurine Treatment of Inflammatory Bowel Disease
Marieke J. H. Coenen et al.
GASTROENTEROLOGY (2015)
Primary-care providers' perceived barriers to integration of genetics services: a systematic review of the literature
Natalie A. Mikat-Stevens et al.
GENETICS IN MEDICINE (2015)
Clinically Actionable Genotypes Among 10,000 Patients With Preemptive Pharmacogenomic Testing
S. L. Van Driest et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2014)
Health Outcomes Associated with Polypharmacy in Community-Dwelling Older Adults: A Systematic Review
Terri R. Fried et al.
JOURNAL OF THE AMERICAN GERIATRICS SOCIETY (2014)
Implementation of personalized medicine services in community pharmacies: Perceptions of independent community pharmacists
Katelyn M. Alexander et al.
JOURNAL OF THE AMERICAN PHARMACISTS ASSOCIATION (2014)
Pilot study of pharmacist-assisted delivery of pharmacogenetic testing in a primary care setting
Susanne B. Haga et al.
PHARMACOGENOMICS (2014)
How common are drug and gene interactions? Prevalence in a sample of 1143 patients with CYP2C9, CYP2C19 and CYP2D6 genotyping
Paul Verbeurgt et al.
PHARMACOGENOMICS (2014)
Guidelines for people not for diseases: the challenges of applying UK clinical guidelines to people with multimorbidity
Lloyd D. Hughes et al.
AGE AND AGEING (2013)
Does Pharmacogenetic Testing for CYP450 2D6 and 2C19 Among Patients with Diagnoses within the Schizophrenic Spectrum Reduce Treatment Costs?
Louise Herbild et al.
BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY (2013)
Pharmacogenetic tests: the need for a level playing field
Munir Pirmohamed et al.
NATURE REVIEWS DRUG DISCOVERY (2013)
A Randomized Trial of Genotype-Guided Dosing of Acenocoumarol and Phenprocoumon
Talitha I. Verhoef et al.
NEW ENGLAND JOURNAL OF MEDICINE (2013)
A Pharmacogenetic versus a Clinical Algorithm for Warfarin Dosing
Stephen E. Kimmel et al.
NEW ENGLAND JOURNAL OF MEDICINE (2013)
A Randomized Trial of Genotype-Guided Dosing of Warfarin
Munir Pirmohamed et al.
NEW ENGLAND JOURNAL OF MEDICINE (2013)
An evaluation of pharmacists' expectations towards pharmacogenomics
Simon de Denus et al.
PHARMACOGENOMICS (2013)
Point-of-care genetic testing for personalisation of antiplatelet treatment (RAPID GENE): a prospective, randomised, proof-of-concept trial
Jason D. Roberts et al.
LANCET (2012)
Epidemiology of multimorbidity and implications for health care, research, and medical education: a cross-sectional study
Karen Barnett et al.
LANCET (2012)
Aging with multimorbidity: A systematic review of the literature
Alessandra Marengoni et al.
AGEING RESEARCH REVIEWS (2011)
Development and implementation of a pharmacist-managed clinical pharmacogenetics service
Kristine R. Crews et al.
AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY (2011)
Assessment of the Pharmacogenomics Educational Needs of Pharmacists
Kristen B. McCullough et al.
AMERICAN JOURNAL OF PHARMACEUTICAL EDUCATION (2011)
Pharmacogenomics: Noninferiority Is Sufficient for Initial Implementation
R. B. Altman
CLINICAL PHARMACOLOGY & THERAPEUTICS (2011)
The prevalence of multimorbidity in primary care and its effect on health care utilization and cost
Liam G. Glynn et al.
FAMILY PRACTICE (2011)
Potentially inappropriate prescribing and cost outcomes for older people: a national population study
Caitriona Cahir et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2010)
Dealing With the Evidence Dilemma in Genomics and Personalized Medicine
M. J. Khoury
CLINICAL PHARMACOLOGY & THERAPEUTICS (2010)
Back to the future: why randomized controlled trials cannot be the answer to pharmacogenomics and personalized medicine
Felix W. Frueh
PHARMACOGENOMICS (2009)
HLA-B*5701 screening for hypersensitivity to abacavir
Simon Mallal et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
分享论文
